» Articles » PMID: 24453336

E2F1 Coregulates Cell Cycle Genes and Chromatin Components During the Transition of Oligodendrocyte Progenitors from Proliferation to Differentiation

Overview
Journal J Neurosci
Specialty Neurology
Date 2014 Jan 24
PMID 24453336
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Cell cycle exit is an obligatory step for the differentiation of oligodendrocyte progenitor cells (OPCs) into myelinating cells. A key regulator of the transition from proliferation to quiescence is the E2F/Rb pathway, whose activity is highly regulated in physiological conditions and deregulated in tumors. In this paper we report a lineage-specific decline of nuclear E2F1 during differentiation of rodent OPC into oligodendrocytes (OLs) in developing white matter tracts and in cultured cells. Using chromatin immunoprecipitation (ChIP) and deep-sequencing in mouse and rat OPCs, we identified cell cycle genes (i.e., Cdc2) and chromatin components (i.e., Hmgn1, Hmgn2), including those modulating DNA methylation (i.e., Uhrf1), as E2F1 targets. Binding of E2F1 to chromatin on the gene targets was validated and their expression assessed in developing white matter tracts and cultured OPCs. Increased expression of E2F1 gene targets was also detected in mouse gliomas (that were induced by retroviral transformation of OPCs) compared with normal brain. Together, these data identify E2F1 as a key transcription factor modulating the expression of chromatin components in OPC during the transition from proliferation to differentiation.

Citing Articles

ENQUIRE automatically reconstructs, expands, and drives enrichment analysis of gene and Mesh co-occurrence networks from context-specific biomedical literature.

Musella L, Afonso Castro A, Lai X, Widmann M, Vera J PLoS Comput Biol. 2025; 21(2):e1012745.

PMID: 39932993 PMC: 11844901. DOI: 10.1371/journal.pcbi.1012745.


Histone H4 acetylation differentially modulates proliferation in adult oligodendrocyte progenitors.

Dansu D, Selcen I, Sauma S, Prentice E, Huang D, Li M J Cell Biol. 2024; 223(11).

PMID: 39133301 PMC: 11318668. DOI: 10.1083/jcb.202308064.


Trametinib, an anti-tumor drug, promotes oligodendrocytes generation and myelin formation.

Yang Y, Suo N, Cui S, Wu X, Ren X, Liu Y Acta Pharmacol Sin. 2024; 45(12):2527-2539.

PMID: 38871922 PMC: 11579360. DOI: 10.1038/s41401-024-01313-9.


DNA hypomethylation activates Cdk4/6 and Atr to induce DNA replication and cell cycle arrest to constrain liver outgrowth in zebrafish.

Madakashira B, Magnani E, Ranjan S, Sadler K Nucleic Acids Res. 2024; 52(6):3069-3087.

PMID: 38321933 PMC: 11014291. DOI: 10.1093/nar/gkae031.


Oligodendrocyte progenitor cells in Alzheimer's disease: from physiology to pathology.

Zou P, Wu C, Liu T, Duan R, Yang L Transl Neurodegener. 2023; 12(1):52.

PMID: 37964328 PMC: 10644503. DOI: 10.1186/s40035-023-00385-7.


References
1.
Ruas M, Peters G . The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta. 1998; 1378(2):F115-77. DOI: 10.1016/s0304-419x(98)00017-1. View

2.
Zhang Y, Liu T, Meyer C, Eeckhoute J, Johnson D, Bernstein B . Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008; 9(9):R137. PMC: 2592715. DOI: 10.1186/gb-2008-9-9-r137. View

3.
Frederick T, Wood T . IGF-I and FGF-2 coordinately enhance cyclin D1 and cyclin E-cdk2 association and activity to promote G1 progression in oligodendrocyte progenitor cells. Mol Cell Neurosci. 2004; 25(3):480-92. DOI: 10.1016/j.mcn.2003.11.015. View

4.
Ivanova I, Vespa A, Dagnino L . A novel mechanism of E2F1 regulation via nucleocytoplasmic shuttling: determinants of nuclear import and export. Cell Cycle. 2007; 6(17):2186-95. DOI: 10.4161/cc.6.17.4650. View

5.
Alonso M, Fueyo J, Shay J, Aldape K, Jiang H, Lee O . Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst. 2005; 97(21):1589-600. DOI: 10.1093/jnci/dji340. View